Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months

Journal of Infectious Diseases

Volumn 184, Issue 7, 2001, Pages 817-826

  Gans, Hayley ^a   Yasukawa, Linda ^a   Rinki, Mary ^a   DeHovitz, Ross ^b   Forghani, Bagher ^c   Beeler, Judith ^d   Audet, Susette ^d   Maldonado, Yvonne ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PALO ALTO MEDICAL FOUNDATION   (United States)

^c 850 Marina Bay Pkwy Richmond C   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MONOCLONAL ANTIBODY; MUMPS VACCINE; VIRUS VACCINE;

ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFANT; INFANT DISEASE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PRIORITY JOURNAL; RUBELLA; TREATMENT OUTCOME; VACCINATION; VIRUS INFECTION;

ADULT; AGE FACTORS; ANTIBODIES, VIRAL; COHORT STUDIES; HUMANS; INFANT; INTERFERON TYPE II; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MORBILLIVIRUS; MUMPS; MUMPS VACCINE; RUBULAVIRUS; T-LYMPHOCYTES; VACCINATION;

EID: 0035479304     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323346     Document Type: Article

References (45)

1. Progress toward global measles control and regional elimination, 1990-1997
2. Global measles control and regional elimination, 1998-1999
3. Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles
4. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine
5. Potential advantages and risks of nucleic acid vaccines for infant immunization
6. Increased susceptibility to measles in infants in the United States
7. Measles outbreaks in the United States, 1987 through 1990
8. The epidemiology of measles: Thirty years of vaccination
9. Measles immunization research: A review
10. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity
11. Changing levels of measles antibody titers in women and children in the United States: Impact on response to vaccination
12. Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers
13. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months
14. Measles immunization: Successes and failures
15. Changes within T cell receptor V beta subsets in infants following measles vaccination
16. Immunosuppression after measles vaccination
17. Changes in cytokine production after measles virus vaccination: Predominant production of IL-4 suggests induction of a Th2 response
18. Immune responses during measles virus infection
19. Pathogenesis of measles virus infection: An hypothesis for altered immune responses
20. Mechanism of suppression of cell-mediated immunity by measles virus
21. Role of virus strain in conventional and enhanced measles plaque neutralization test
22. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody
23. Assay of humoral immunity to mumps virus
24. Measles antibody: Reevaluation of protective titers
25. Measles eradication: Experience in the Americas
26. Ontogeny of CD40L [corrected] expression by activated peripheral blood lymphocytes in humans
27. Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn
28. - T cell functions
29. CD40 and its ligand in the regulation of humoral immunity
30. Developmental immunology and role of the host defenses in neonatal susceptibility to infection
31. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies
32. Studies of human cord blood dendritic cells: Evidence for functional immaturity
33. Activation of human dendritic cells through CD40 cross-linking
34. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination
35. Interleukin 12, interferon-γ and T cell proliferation to measles in immunized infants
36. Kinetics of immunologic responses after primary MMR vaccination
37. Generation of defective interfering particles by two vaccine strains of measles virus
38. Immune activation in measles
39. Measles
40. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal
41. Vaccinated children get milder measles infection: A community study from Guinea-Bissau
42. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies
43. Influence of maternal antibodies on vaccine responses: Inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice
44. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells